 |
|
|
|
|
|
NEWS RELEASE:
FOR IMMEDIATE RELEASE:
|
Contact:
Jacques Cornet, VP of Business Development & Strategic Marketing
Cedara Software Corp.
905.672.2100 x-2564 jacques.cornet@cedara.com
|
|
Media Contact:
Beth Frost-Johnson, Sr. VP of Marketing
Merge Healthcare
(414) 977-4254
bethfj@merge.com
|
|
Attention: Business/Financial Editors:
CEDARA AND SWISSRAY SIGN AGREEMENT TO DELIVER COMPREHENSIVE DIGITAL ORTHOPAEDIC SOLUTION TO HEALTHCARE PROVIDERS
- Swissray to market Cedara's OrthoWorks software as their orthopaedic solution
- Agreement provides Swissray with Cedara's next generation orthopaedic workstation, Cedara OrthoWorks ProPlanner™, as part of their integrated solution for orthopaedic imaging
- Offering to include powerful diagnostic review and planning functionality for joint arthroplasty, trauma, deformity corrections and more
Toronto, ON, May 1, 2006 – Cedara Software, a Merge Healthcare company (NASDAQ: MRGE; TSX: MRG) and a leading independent developer of medical software technologies for the global healthcare market, today announced an agreement with Swissray International where Swissray will distribute Cedara's new orthopaedic workstation, Cedara OrthoWorks ProPlanner, to their customers worldwide as part of an integrated solution with their Digital Radiography (DR) systems.
Swissray is a global leader in the design, manufacturing and marketing of direct digital radiography – ddR - systems. The Orthopaedic community has been drawn to the value proposition that Swissray offers with the fastest and most automated low dose DR systems on the market. This agreement will allow Swissray to provide its customers with a complete solution for Orthopaedic imaging using next generation technology contained in OrthoWorks ProPlanner.
Ueli Laupper, Swissray Sr. VP of Sales and Marketing stated, "With over 500 Swissray DR systems sold we have always delivered the highest quality digital images, cost savings and efficiency in radiography. Swissray has focused on the Orthopaedic market for many years and fully understands the needs and challenges of orthopaedic imaging better than any other DR supplier. Our partnership with Cedara allows us to offer the most advanced orthopaedic software solutions available today."
Cedara's orthopaedic software provides support for deformity corrections, trauma and customized planning methodologies that mimic orthopaedic workflow which currently cannot be planned manually. In challenging deformity and trauma corrective cases for example, Image Cutting allows surgeons to digitally cut and reposition fractured bone fragments to visualize potential surgical changes. In converse circumstances, Image Stitching allows users to stitch together two or more images using a number of methods to ensure that cases requiring long film X-rays can still be digitally planned without the need for expensive stitching hardware. OrthoWorks ProPlanner also incorporates Cedara's ImageSnap Technology™, a unique capability that enables automatic measurements with suggested implant selection and placement.
"We are very excited about our new relationship with Swissray," said Brian Pedlar, President of Cedara Software. "The combination of Swissray's reputation for delivering the highest quality digital images, cost savings and efficiency combined with our orthopaedic solutions that provide a high level of flexibility to accommodate the work patterns of different surgeons, while still providing advanced diagnostic capabilities will bring a new level of flexibility, power and digital support to Swissray's customers worldwide."
###
Swissray has received from Frost & Sullivan the "Best Product Value" award for their market leading digital radiography systems. This new technology provides high quality medical radiographic images in seconds at a significantly lower cost than conventional or computed radiography because, among other factors, film, imaging plates, cassettes and chemical processing are not required. By utilizing a multifunctional single detector design, Swissray offers an affordable high quality solution for direct digital radiography. Swissray currently provides a full range of DR systems for orthopedic applications, imaging centers, hospitals and emergency departments. All of Swissray's DR systems include the APS™ – Automated Positioning System for fully automated, remote controlled system positioning. Swissray offers customers choice between amorphous silicon flat panel or their unique 16 bit Quad CCD detector technologies. For additional information visit www.swissray.com
Cedara Software is a Merge Healthcare company focused on the development of custom engineered software applications and development tools for the medical imaging OEM and International markets. Cedara software is deployed in hospitals and clinics worldwide and is licensed by many of the world's leading medical device and healthcare information technology companies. Cedara technologies and expertise span all the major digital imaging modalities including computed tomography (CT), magnetic resonance imaging (MRI), digital X-ray, mammography, ultrasound, echo-cardiology, angiography, nuclear medicine, positron emission tomography (PET) and fluoroscopy. Cedara medical imaging offerings are used in all aspects of clinical imaging workflow including the capture of a patient's digital image; the archiving, communication and manipulation of digital images; sophisticated clinical applications to analyze digital images; and the use of imaging in minimally-invasive surgery. For additional information, visit our website at www.cedara.com.
Merge Healthcare is a market leader in the development and delivery of medical imaging and information management software and services. With over twenty years of leadership in the medical imaging and healthcare information technology markets, Merge Healthcare provides innovative solutions for both OEM and the end-user healthcare markets. We custom engineer clinical and imaging applications and development tools that are on the forefront of medicine and its use of medical imaging for OEM and international customers. We develop innovative medical imaging software solutions that support end-to-end business and clinical workflow for radiology department and specialty practices, imaging centers and hospitals. Our innovative software solutions use leading-edge imaging software technologies that accelerate market delivery for our OEM customers, while our end-user solutions improve our customers' productivity and enhance the quality of patient care they provide. For additional information, visit our website at www.merge.com.
All trademarks appearing in this release are the property of Cedara Software Corp. and/or Merge Healthcare.
|
Attn: Beth Frost-Johnson
Merge Healthcare
6737 West Washington St.
Suite 2250
Milwaukee, WI 53214
|
|
|
|
|
|
| Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, the forward-looking statements based on a number of factors, including, but not limited to, the uncertainty created by, the adverse impact on relationships with customers, potential customers, suppliers and investors potentially resulting from, and other risks associated with, the changes in the Company’s senior management; costs, risks and effects of the investigation by the Audit Committee of the Board of Directors; the impact of the restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company's inability to timely file reports with the Securities and Exchange Commission; risks associated with the Company's inability to meet the requirements of The NASDAQ Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the informal, non-public inquiry being conducted by the Securities and Exchange Commission and class action, derivative, and other lawsuits; risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in the Company’s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.
|
|
|
